Top Markets
#1 Akedo Akedo +146.29%
#2 TENDIES TENDIES +96.27%
#3 Threshold Network Threshold Network +47.05%
#4 Verus Coin Verus Coin +43.84%
#5 Mubarak Mubarak +27.69%
#6 Bitway Bitway +26.92%
#7 MultiversX MultiversX +23.94%
#8 Palladium Network Palladium Network +22.69%
#9 Cash Cat Cash Cat +22.59%
#10 aelf aelf +19.17%
Coin of the day
Akedo Akedo
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Regulus Therapeutics Inc. Regulus Therapeutics Inc.

Regulus Therapeutics Inc.

RGLS
Kedudukan dalam Saham #17600
Regulus Therapeutics Inc., a biopharmaceutical firm in its clinical development... Regulus Therapeutics Inc., a biopharmaceutical firm in its clinical development phase, is dedicated to uncovering and advancing novel medications. Based in San Diego, California, the company's core focus is on modulating microRNAs to combat a variety of diseases across the United States. Its current pipeline highlights RG-012, an anti-miR compound engineered to inhibit miR-21, which is currently in a Phase II clinical study for Alport syndrome, a severe renal condition. Another significant candidate, RGLS8429, an anti-miR agent targeting miR-17, is being evaluated in a Phase 1b clinical trial for autosomal dominant polycystic kidney disease. Beyond these clinical programs, Regulus is also cultivating an extensive preclinical portfolio, emphasizing drug candidates with precise, organ-selective delivery strategies. The company was established in 2007.
Harga Saham
$8.16
Disegerakkan terakhir: 2025-06-26
Modal Pasaran
$234.57M
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan Regulus Therapeutics Inc. (RGLS)

Kategori

Healthcare
Margin Operasi untuk Regulus Therapeutics Inc. (RGLS)
Margin Operasi pada September 2026 TTM: 0.00%
Menurut laporan kewangan dan harga saham terkini Regulus Therapeutics Inc., margin operasi semasa (TTM) ialah 0.00%. Pada akhir 2023, margin operasi syarikat ialah 0.00%.
Sejarah Margin Operasi untuk Regulus Therapeutics Inc. dari 2010 hingga 2026
Margin Operasi pada akhir setiap tahun
Tahun Margin Operasi Ubah
2026 (TTM) 0.00% 0.00%
2024 0.00% 0.00%
2023 0.00% 0.00%
2022 0.00% 0.00%
2021 0.00% -100.00%
2020 -141.47% -42.59%
2019 -246.40% -99.62%
2018 -64,948.61% -33.32%
2017 -97,404.17% 1,326.97%
2016 -6,825.96% 2,487.75%
2015 -263.78% -54.96%
2014 -585.60% 543.73%
2013 -90.97% -8.12%
2012 -99.01% 91.29%
2011 -51.76% -71.27%
2010 -180.19% 0.00%
Margin Operasi untuk syarikat serupa atau pesaing
Syarikat Margin Operasi Perbezaan Margin Operasi Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
38.59% -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
28.81% -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
-149.01% -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
25.57% -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00% -
CH
Apakah Margin Operasi sesebuah syarikat?
Margin Operasi ialah penunjuk utama untuk menilai keuntungan sesebuah syarikat. Margin Operasi yang lebih tinggi lazimnya lebih baik kerana menunjukkan bahawa syarikat mampu menjual produk atau perkhidmatannya dengan harga yang jauh lebih tinggi daripada kos pengeluarannya. Ia dikira dengan membahagikan keuntungan syarikat dengan hasilnya.